Journal of neurosurgery · 1974 · 75 citations · 43 references
MedicineNeurobiologyNeuroscienceNeurochemistryNeuropharmacologyPsychopharmacologyDopaminergic PharmacologyNeuroprotectionSpinal Cord InjurySpinal TraumaTraumatic Brain InjuryVeterinary NeuropharmacologyNeurobiological Effects Of TraumaNeuroprotection In Spinal TraumaPilot Study DesignSpinal Cord Injury ModelsSpinal Cord Injury NeuroprotectionSpinal Cord Injury PathophysiologySpinal Cord Injury PhysiologyTraumatic Spinal Cord Injury
✓ A chronic clinicopathological study in 43 mongrel dogs evaluates the therapeutic effect of microcirculatory augmentation, an anti-edema agent, catecholamine (CA) receptor blockers, and a CA synthesis inhibitor. Results showed a high degree of clinical protection conferred by phenoxybenzamine, an alpha-adrenergic receptor blocker, and a lesser degree of protection from haloperidol, a domaminergic blocker, and low molecular weight dextran. Alpha-methyltyrosine given post-injury and steroids were of no therapeutic value. There was a correlation between microscopic white matter protection and clinical result. The presence of central gray necrosis was rather constant irrespective of therapy or clinical result.
43